Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
Diabetes care needs to support lifestyle changes – not pharmaceutical intervention – first
While pharmaceuticals are a critical piece of the treatment landscape for type 2 diabetes, they have been the exclusive and de-facto first-line treatment for too long. Prescription digital therapeutics can and should be considered as part of type 2 diabetes therapies.
At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
FDA clears first VR-based tool for for lower-back pain
The Food and Drug Administration granted the company de novo clearance for its VR programs to help reduce chronic lower back pain. AppliedVR’s eight-week program is based on cognitive behavioral therapy.